Clinical Trial Update: The Effect of Rifabutin in Mycobacterium Abscessus With Inducible Clarithromycin Resistance [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating rifabutin for Mycobacterium abscessus lung disease with inducible clarithromycin resistance; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Abscessus Lung Disease

Drugs mentioned

• RIFABUTIN (Rifabutin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Mycobacterium Abscessus Lung Disease | Phase 4 | Status: RECRUITING